PRELUDE CAPITAL MANAGEMENT, LLC - LUX HEALTH TECH ACQUISITION ownership

LUX HEALTH TECH ACQUISITION's ticker is LUXA and the CUSIP is 55068A100. A total of 67 filers reported holding LUX HEALTH TECH ACQUISITION in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 1.4%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of LUX HEALTH TECH ACQUISITION
ValueSharesWeighting
Q1 2022$992,000
-32.8%
100,600
-33.2%
0.03%
-23.7%
Q4 2021$1,476,000
-10.3%
150,600
-10.2%
0.04%
-9.5%
Q3 2021$1,645,000
+139.8%
167,700
+141.8%
0.04%
+110.0%
Q2 2021$686,000
+566.0%
69,357
+593.6%
0.02%
+566.7%
Q1 2021$103,00010,0000.00%
Other shareholders
LUX HEALTH TECH ACQUISITION shareholders Q1 2022
NameSharesValueWeighting ↓
Wolfswood Holdings, LLC 1,700,000$16,813,00084.84%
MYDA Advisors LLC 900,000$8,901,0002.49%
Empyrean Capital Partners, LP 3,000,649$29,676,0000.94%
Tuttle Capital Management, LLC 30,166$298,0000.83%
Silver Rock Financial LP 369,442$3,654,0000.80%
BBR PARTNERS, LLC 639,999$6,330,0000.74%
Governors Lane LP 725,000$7,170,0000.57%
Mint Tower Capital Management B.V. 606,757$6,001,0000.48%
Spartan Fund Management Inc. 226,753$2,243,0000.48%
Privium Fund Management (UK) Ltd 40,353$399,0000.45%
View complete list of LUX HEALTH TECH ACQUISITION shareholders